San Diego, CA, United States of America

Ruth Wei Aranda

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ruth Wei Aranda: Innovator in Cancer Treatment

Introduction

Ruth Wei Aranda is a prominent inventor based in San Diego, CA, known for her significant contributions to cancer treatment. With a focus on innovative combination therapies, she has developed methods that target KRas G12C cancers. Her work is vital in the ongoing battle against cancer, providing new hope for patients in need.

Latest Patents

Ruth Wei Aranda holds 4 patents related to her groundbreaking research. Her latest patents include innovative combination therapies for treating KRas G12C cancers. These inventions involve administering a therapeutically effective amount of a combination of a SHP-2 inhibitor and a KRAS G12C inhibitor, as well as a pan ErbB family inhibitor and a KRAS G12C inhibitor. Both patents detail pharmaceutical compositions and methods of use that are crucial for effective cancer treatment.

Career Highlights

Ruth is currently associated with Mirati Therapeutics, Inc., where she continues to advance her research in cancer therapies. Her work is characterized by a commitment to developing effective treatments that can significantly improve patient outcomes.

Collaborations

Ruth has collaborated with notable colleagues, including James Gail Christensen and Lars Daniel Engstrom. These partnerships enhance her research efforts and contribute to the development of innovative cancer therapies.

Conclusion

Ruth Wei Aranda is a trailblazer in the field of cancer treatment, with her innovative patents paving the way for new therapeutic approaches. Her dedication to improving patient care through research is commendable and highlights the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…